MovDisordV3, Main, Exploration, bibRecord, 003698

Toward future therapies in progressive supranuclear palsy

Identifieur interne : 003698 ( Main/Exploration ); précédent : 003697; suivant : 003699

Toward future therapies in progressive supranuclear palsy

Auteurs : David J. Burn [Royaume-Uni] ; Naomi M. Warren [Royaume-Uni]

Source :

Movement Disorders [ 0885-3185 ] ; 2005-08.

RBID : ISTEX:F7957A9A6A75DE74DDE1FB7BEC862510BE576CD8

Descripteurs français

Pascal (Inist)
- Facteur trophique, Système nerveux pathologie, Traitement.

English descriptors

KwdEn :
- Adrenergic Agents (therapeutic use), Anti-Dyskinesia Agents (therapeutic use), Cholinergic Agents (therapeutic use), Dopamine Agents (therapeutic use), Humans, Nervous system diseases, Neurotransmitter Agents (therapeutic use), Palliative Care, Steele–Richardson–Olszewski syndrome, Supranuclear Palsy, Progressive (drug therapy), Supranuclear Palsy, Progressive (therapy), Treatment, Trophic factor, progressive supranuclear palsy, treatment, trophic factors.
MESH :
- chemical , therapeutic use : Adrenergic Agents, Anti-Dyskinesia Agents, Cholinergic Agents, Dopamine Agents, Neurotransmitter Agents.
- drug therapy : Supranuclear Palsy, Progressive.
- therapy : Supranuclear Palsy, Progressive.
- Humans, Palliative Care.

Abstract

There is a stern therapeutic challenge for progressive supranuclear palsy (PSP) that has not yet been met. The lack of randomized, controlled trials and negative outcomes from the vast majority of studies make it impossible to set therapeutic standards, or to give clear recommendations. We review progress to date in this area and briefly consider future potential therapeutic strategies. © 2005 Movement Disorder Society

Url:

https://api.istex.fr/document/F7957A9A6A75DE74DDE1FB7BEC862510BE576CD8/fulltext/pdf

DOI: 10.1002/mds.20546

Affiliations:

Royaume-Uni

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Toward future therapies in progressive supranuclear palsy</title>
<author><name sortKey="Burn, David J" sort="Burn, David J" uniqKey="Burn D" first="David J." last="Burn">David J. Burn</name>
</author>
<author><name sortKey="Warren, Naomi M" sort="Warren, Naomi M" uniqKey="Warren N" first="Naomi M." last="Warren">Naomi M. Warren</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:F7957A9A6A75DE74DDE1FB7BEC862510BE576CD8</idno>
<date when="2005" year="2005">2005</date>
<idno type="doi">10.1002/mds.20546</idno>
<idno type="url">https://api.istex.fr/document/F7957A9A6A75DE74DDE1FB7BEC862510BE576CD8/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001E31</idno>
<idno type="wicri:Area/Istex/Curation">001E31</idno>
<idno type="wicri:Area/Istex/Checkpoint">002104</idno>
<idno type="wicri:doubleKey">0885-3185:2005:Burn D:toward:future:therapies</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:16092097</idno>
<idno type="wicri:Area/PubMed/Corpus">002F30</idno>
<idno type="wicri:Area/PubMed/Curation">002F30</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002F30</idno>
<idno type="wicri:Area/Ncbi/Merge">001382</idno>
<idno type="wicri:Area/Ncbi/Curation">001382</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001382</idno>
<idno type="wicri:doubleKey">0885-3185:2005:Burn D:toward:future:therapies</idno>
<idno type="wicri:Area/Main/Merge">004D81</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:05-0457452</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001D80</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000F41</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">001C85</idno>
<idno type="wicri:doubleKey">0885-3185:2005:Burn D:toward:future:therapies</idno>
<idno type="wicri:Area/Main/Merge">005163</idno>
<idno type="wicri:Area/Main/Curation">003698</idno>
<idno type="wicri:Area/Main/Exploration">003698</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Toward future therapies in progressive supranuclear palsy</title>
<author><name sortKey="Burn, David J" sort="Burn, David J" uniqKey="Burn D" first="David J." last="Burn">David J. Burn</name>
<affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Neurology, Regional Neurosciences Centre, Newcastle General Hospital and Institute for Ageing and Health, University of Newcastle upon Tyne, Newcastle upon Tyne</wicri:regionArea>
<wicri:noRegion>Newcastle upon Tyne</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Warren, Naomi M" sort="Warren, Naomi M" uniqKey="Warren N" first="Naomi M." last="Warren">Naomi M. Warren</name>
<affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Neurology, Regional Neurosciences Centre, Newcastle General Hospital and Institute for Ageing and Health, University of Newcastle upon Tyne, Newcastle upon Tyne</wicri:regionArea>
<wicri:noRegion>Newcastle upon Tyne</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2005-08">2005-08</date>
<biblScope unit="vol">20</biblScope>
<biblScope unit="issue">S12</biblScope>
<biblScope unit="supplement">S12</biblScope>
<biblScope unit="page" from="S92">S92</biblScope>
<biblScope unit="page" to="S98">S98</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">F7957A9A6A75DE74DDE1FB7BEC862510BE576CD8</idno>
<idno type="DOI">10.1002/mds.20546</idno>
<idno type="ArticleID">MDS20546</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adrenergic Agents (therapeutic use)</term>
<term>Anti-Dyskinesia Agents (therapeutic use)</term>
<term>Cholinergic Agents (therapeutic use)</term>
<term>Dopamine Agents (therapeutic use)</term>
<term>Humans</term>
<term>Nervous system diseases</term>
<term>Neurotransmitter Agents (therapeutic use)</term>
<term>Palliative Care</term>
<term>Steele–Richardson–Olszewski syndrome</term>
<term>Supranuclear Palsy, Progressive (drug therapy)</term>
<term>Supranuclear Palsy, Progressive (therapy)</term>
<term>Treatment</term>
<term>Trophic factor</term>
<term>progressive supranuclear palsy</term>
<term>treatment</term>
<term>trophic factors</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Adrenergic Agents</term>
<term>Anti-Dyskinesia Agents</term>
<term>Cholinergic Agents</term>
<term>Dopamine Agents</term>
<term>Neurotransmitter Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Supranuclear Palsy, Progressive</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Supranuclear Palsy, Progressive</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
<term>Palliative Care</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Facteur trophique</term>
<term>Système nerveux pathologie</term>
<term>Traitement</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">There is a stern therapeutic challenge for progressive supranuclear palsy (PSP) that has not yet been met. The lack of randomized, controlled trials and negative outcomes from the vast majority of studies make it impossible to set therapeutic standards, or to give clear recommendations. We review progress to date in this area and briefly consider future potential therapeutic strategies. © 2005 Movement Disorder Society</div>
</front>
</TEI>
<affiliations><list><country><li>Royaume-Uni</li>
</country>
</list>
<tree><country name="Royaume-Uni"><noRegion><name sortKey="Burn, David J" sort="Burn, David J" uniqKey="Burn D" first="David J." last="Burn">David J. Burn</name>
</noRegion>
<name sortKey="Warren, Naomi M" sort="Warren, Naomi M" uniqKey="Warren N" first="Naomi M." last="Warren">Naomi M. Warren</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003698 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003698 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:F7957A9A6A75DE74DDE1FB7BEC862510BE576CD8
   |texte=   Toward future therapies in progressive supranuclear palsy
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

Movement Disorders (revue)

Toward future therapies in progressive supranuclear palsy

Toward future therapies in progressive supranuclear palsy

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.